The global pneumonia testing market size hit USD 557.1 million in 2021. The market valuation is slated to rise from USD 606.6 million in 2022 to USD 912.5 million by 2029, recording 6% CAGR during 2022-2029. This information is provided by Fortune Business Insights in its report titled “Pneumonia Testing Market, 2022-2029”.

Key Industry Development:

April 2022: bioMérieux SA acquired Specific Diagnostics, a company that developed a rapid Antimicrobial Susceptibility Test (AST) system that directly delivers phenotypic AST from positive blood cultures.

Request a Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pneumonia-testing-market-106787

Regional Insights:      

The North American Market Stood at USD 221.4 Million in 2021

North America dominated the pneumonia testing market share in 2021 with USD 221.4 million. The region will continue to hold the dominant market share through 2029 led by growing pneumonia cases, rapid adoption of point-of-care technologies, and supportive reimbursement policies.

The European market holds the second-largest market share and will experience growth led by growing number of hospital admissions related to pneumonia. Meanwhile, the market in Asia Pacific will grow on account of a large geriatric population.

To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:

https://www.fortunebusinessinsights.com/pneumonia-testing-market-106787

Drivers & Restraints:

Widespread Prevalence of Pneumonia to Boost Market Growth   

The prevalence of pneumonia among the world's population is the main factor fueling the market expansion. Growing prevalence of the illness, increased complications, and other health issues among pneumonia sufferers may open up new prospects for market expansion. The respective public health organizations’ ongoing initiatives to increase pneumonia testing will have a beneficial effect on the market dynamics in the years to come.

However, wide use of x-ray for pneumonia detection may hamper the market prospects. 

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd

U.S.: +1 424 253 0390

U.K.: +44 2071 939123

APAC: +91 744 740 1245

Email: sales@fortunebusinessinsights.com